All News Energy News Space

Generalized Pustular Psoriasis Market Insights, Treatment and Market Growth by DelveInsight

DelveInsight has launched a new report on Generalized Pustular Psoriasis Market

Generalized Pustular Psoriasis (GPP) is a subtype of pustular psoriasis characterized by painful and occasionally disfiguring cutaneous manifestations with sepsis-like systemic symptoms. Psoriasis is an immune-mediated disease being characterized by red scaly patches on the skin. It is clinically classified into two groups: pustular and non-pustular lesions. Non-pustular psoriasis is further subdivided into Psoriasis vulgaris (early and late onset), Guttate psoriasis, Erythrodermic psoriasis, Palmoplantar psoriasis, Psoriatic arthritis (PsA), and Inverse psoriasis. The Pustular variant of the psoriasis is further subdivided into generalized and localized forms. The generalized form of pustular psoriasis is a potentially life-threatening, multisystemic inflammatory disease characterized by sudden, repeated episodes of high-grade fever, generalized erythematous pustular rashes, painful and occasionally disfiguring cutaneous manifestations with sepsis-like.

The Generalized Pustular Psoriasis market report provides an understanding of the epidemiology and changing market dynamics of Generalized Pustular Psoriasis (GPP) in the seven major pharmaceutical markets for the period 2017–2030

Get a free Generalized Pustular Psoriasis market report sample page-

Generalized Pustular Psoriasis Treatment

The current therapeutic landscape of GPP in the United States is driven by supportive therapies (topical therapies, systemic therapies, biologics, and phototherapy). In EU-5 countries, for GPP, the market is the same as that of the US, with prescriptions for supportive therapies, due to lack of approved treatment regimens. In contrast to the US and EU-5 countries, the current therapeutic landscape of GPP in Japan is driven by a number of approved therapies, along with supportive treatment regimens.

Generalized Pustular Psoriasis Key Strengths

  • 11 Year Forecast
  • 7MM Coverage
  • Epidemiology Segmentation
  • Drugs Uptake
  • Highly Analyzed Market
  • Key Cross Competition
  • Market Size by Country
  • Market Size by Therapy

Key companies of the report

  • Janssen Pharmaceuticals
  • Novartis
  • Kyowa Hakko Kirin
  • AbbVie/Boehringer Ingelheim
  • AbbVie/Eisai
  • Eli Lilly & Company

Generalized Pustular Psoriasis Market Size

The dynamics of the GPP market are anticipated to change in the coming years owing to the expected launch of emerging therapies during the forecasted period of 2020–2030. With this, several companies have shifted their focus toward this therapeutic area, and two of the therapies are expected to enter the treatment market of GPP during our forecast period, namely BI 655130 (Boehringer Ingelheim) and Imsidolimab (ANB019) (AnaptysBio).

Regions covered in Generalized Pustular Psoriasis report

  • United States,
  • Germany
  • Spain
  • Italy
  • France
  • United Kingdom
  • Japan

Get a free Generalized Pustular Psoriasis market report sample page-

Table of content

  1. Key Insights
  2. Generalized Pustular Psoriasis (GPP): Market Overview at a Glance
  3. Generalized Pustular Psoriasis (GPP): Disease Background and Overview
  4. Epidemiology and Patient Population
  5. United States Epidemiology
  6. EU5 Epidemiology
  7. Japan Epidemiology
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Proposed Guidelines for the Diagnosis and Treatment of GPP
  10. Unmet Needs
  11. Marketed Products
  12. Emerging Therapies
  13. GPP: 7MM Market Analysis
  14. United States: Market Outlook
  15. EU-5 countries: Market Outlook
  16. Japan Market Outlook
  17. Market Drivers
  18. Market Barriers
  19. Appendix
  20. DelveInsight Capabilities
  21. Disclaimer
  22. About DelveInsight

 Generalized Pustular Psoriasis Key benefits

  • This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving Generalized Pustular Psoriasis market
  • Organize sales and marketing efforts by identifying the best opportunities for Generalized Pustular Psoriasis market
  • To understand the future market competition in the GPP market

Check latest blogs–

Contact us

Shruti Thakur

[email protected]


LinkedIn | Facebook | Twitter